Passage Bio
PASG
35 hedge funds and large institutions have $13.8M invested in Passage Bio in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
17% more funds holding
Funds holding: 30 → 35 (+5)
5.87% more ownership
Funds ownership: 49.62% → 55.49% (+5.9%)
26% less capital invested
Capital invested by funds: $18.6M → $13.8M (-$4.78M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$705K |
| 2 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$536K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$270K |
| 4 |
Renaissance Technologies
New York
|
+$254K |
| 5 |
VA
Verdad Advisers
Boston,
Massachusetts
|
+$229K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$208K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$168K |
| 3 |
QC
Quadrature Capital
London,
United Kingdom
|
-$148K |
| 4 |
Squarepoint
New York
|
-$127K |
| 5 |
NCNMGF
Nano-Cap New Millennium Growth Fund
Staten Island,
New York
|
-$118K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $903 | +$1.19K | +115 | New |
|
|
PA
27
Parallel Advisors
San Francisco,
California
| $126 | – | – | – |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $117 | -$52 | -5 | -25% |
|
29
BNP Paribas Financial Markets
Paris,
France
| $94 | – | – | – |
|
|
LI
30
LRI Investments
Palm Beach Gardens,
Florida
| $94 | – | – | – |
|
31
JP Morgan Chase
New York
| $93 | – | – | – |
|
|
HI
32
Harbour Investments
Madison,
Wisconsin
| $24 | – | – | – |
|
33
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $8 | – | – | – |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$208K | -17,660 | Closed |
|
|
35
Northern Trust
Chicago,
Illinois
| – | -$168K | -14,217 | Closed |
|
|
QC
36
Quadrature Capital
London,
United Kingdom
| – | -$148K | -12,578 | Closed |
|
|
37
Squarepoint
New York
| – | -$127K | -10,799 | Closed |
|
|
NCNMGF
38
Nano-Cap New Millennium Growth Fund
Staten Island,
New York
| – | -$118K | -10,000 | Closed |
|
39
Bank of America
Charlotte,
North Carolina
| – | -$331 | -28 | Closed |
|
40
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$21 | +2 | New |
|
PASG Hedge Fund Activity: Q1 2026 in Review
35 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q1 2026, worth a combined $13.8M — down 26% from $18.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PASG positions and 6 closed out — a net gain of 6 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $705K. The largest seller was Citadel Advisors, exiting entirely with an estimated $208K sold.
- 35 institutional investors held Passage Bio (PASG) as of Q1 2026, up from 30 in Q4 2025.
- Funds reported $13.8M of Passage Bio stock for Q1 2026, down 26% quarter-over-quarter.
- 12 funds opened new Passage Bio positions in Q1 2026 and 6 closed out, a net change of +6 holders.
- The largest Passage Bio buyer in Q1 2026 was Ikarian Capital, an estimated $705K added.
- The largest Passage Bio seller in Q1 2026 was Citadel Advisors, an estimated $208K sold.
Based on aggregated 13F filings for Q1 2026.